Abstract
Discover how the right pre-fillable syringe strategy can help address the complex containment and delivery requirements of biologic drug products.
The growing adoption of biologics, the shift toward self-administration, and the increasing concentration of formulations are creating new challenges for pre-filled syringe systems. Sensitive drug products may require careful management of silicone-related interactions, while high-viscosity formulations and integration with autoinjectors demand optimized container dimensions, mechanical performance, and needle configurations.
In this webinar, Stevanato Group explores how early-stage analytical services, advanced syringe platforms, and data-driven development approaches can support the selection of an appropriate containment solution. The session examines strategies for reducing silicone oil-related challenges, supporting consistent functional performance, facilitating integration with autoinjectors, and addressing the delivery of high-viscosity formulations.
The session will highlight how to:
- Apply early-stage analytical testing to support container selection and de-risk combination product development
- Address silicone-related challenges for sensitive biologics through advanced pre-filled syringe solutions
- Optimize syringe and needle configurations to support autoinjector integration and the delivery of high-viscosity formulations
By combining analytical expertise, specialized syringe technologies, and predictive modeling, pharmaceutical companies can make more informed container-selection decisions and support the development of reliable, patient-centric drug delivery solutions.
